S&P 및 Nasdaq 내재가치 문의하기

Intensity Therapeutics, Inc. INTS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
42/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
-5.7%

총 31 건의 최근 내부자 거래 내역가 기록되었습니다 Intensity Therapeutics, Inc. (INTS), 포함 23 건 매수6 건 매도. 내부자 매수 총액은 $4.89M 내부자 매도 총액은 $1.78M.

최근 활동이 있는 주요 내부자에는 Bender Lewis H, Talamo Joseph, Wesolowski John M. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — INTS

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2026-03-26 Bender Lewis H President and CEO RSU 부여 37,749 $6.11 $230.65K 118,549
2025-12-31 Talamo Joseph Chief Financial Officer RSU 부여 14,482 $0.26 $3.79K 28,661
2025-12-31 Wesolowski John M Principal Accounting Officer RSU 부여 8,918 $0.26 $2.34K 85,354
2025-06-30 Talamo Joseph Chief Financial Officer RSU 부여 14,179 $0.26 $3.7K 14,179
2025-06-30 Wesolowski John M Principal Accounting Officer RSU 부여 69,745 $0.26 $18.2K 76,436
2025-05-02 Dubin Thomas I H Director RSU 부여 50,000 $0.57 $28.5K 50,000
2025-05-02 Bender Lewis H 10 Percent Owner, Officer: President and CEO RSU 부여 700,000 $0.57 $399K 700,000
2025-05-02 Goldberg Mark A Director RSU 부여 50,000 $0.57 $28.5K 50,000
2025-05-02 Talamo Joseph Chief Financial Officer RSU 부여 300,000 $0.57 $171K 300,000
2025-05-02 Leahy Emer Director RSU 부여 50,000 $0.57 $28.5K 50,000
2025-05-02 Wesolowski John M Principal Accounting Officer RSU 부여 100,000 $0.57 $57K 100,000
2025-05-02 Donovan Daniel Director RSU 부여 50,000 $0.57 $28.5K 50,000
2024-10-21 Talamo Joseph Chief Financial Officer RSU 부여 427,379 $3.44 $1.47M 427,379
2024-10-21 Wesolowski John M Principal Accounting Officer RSU 부여 70,028 $3.44 $240.9K 70,028
2024-06-05 Wesolowski John M Principal Accounting Officer 옵션 행사 1,000 $4.00 $4K 6,691
2024-05-14 Dubin Thomas I H Director 알 수 없음 - - - -
2024-05-14 Dubin Thomas I H Director RSU 부여 50,000 $4.42 $221K 50,000
2024-03-06 Bender Lewis H 10 Percent Owner, Officer: President and CEO RSU 부여 33,574 $5.19 $174.25K 33,574
2024-03-06 Goldberg Mark A Director RSU 부여 50,000 $5.19 $259.5K 50,000
2024-03-06 Leahy Emer Director RSU 부여 50,000 $5.19 $259.5K 50,000
2024-03-06 Wesolowski John M See Remarks RSU 부여 25,000 $5.19 $129.75K 25,000
2024-03-06 Donovan Daniel Director RSU 부여 50,000 $5.19 $259.5K 50,000
2023-12-11 Talamo Joseph Officer 알 수 없음 - - - -
2023-12-11 Talamo Joseph Chief Financial Officer RSU 부여 80,000 $6.88 $550.4K 80,000
2023-07-19 Wesolowski John M Interim CFO RSU 부여 50,000 $6.43 $321.5K 50,000
2023-06-29 Bender Lewis H 10 Percent Owner, Officer: President and CEO 처분 75,000 $11.50 $862.5K -
2023-06-29 Goldberg Mark A Director 처분 25,000 $11.50 $287.5K -
2023-06-29 Ahlers James M Executive VP of Cf 처분 5,000 $9.00 $45K -
2023-06-29 Leahy Emer Director 처분 25,000 $11.50 $287.5K -
2023-06-29 Wesolowski John M Interim CFO 처분 6,500 $11.50 $74.75K -
2023-06-29 Donovan Daniel Director 처분 25,000 $9.00 $225K -
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기